For the first time, researchers have confirmed an association between a common magnetic resonance imaging (MRI) contrast agent and abnormalities on brain MRI, according to a new study published online in the journal Radiology. The new study raises the possibility that a toxic component of the contrast agent may remain in the body long after administration.Brain MRI exams are often performed with a gadolinium-based contrast medium (Gd-CM).
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment